Yahoo Finance

• Consolidated Net Sales: Approximately $1.4 billion, consistent with prior year.

• Adjusted EBITDA: $166 million, down from $191 million in the prior year.

• Net Loss: $4 million or $0.03 per diluted share, compared to net income of $54 million or $0.36 per diluted share in the prior year.

• TSS Net Sales: $466 million, a 3% increase from the prior year.

• TSS Adjusted EBITDA Margin: 30%, decreased by 3 percentage points.

• TT Net Sales: $597 million, a 1% increase year-over-year.

• TT Adjusted EBITDA: $50 million, a 28% decrease compared to the prior year.

• APM Net Sales: $294 million, a 3% decrease compared to the prior year.

• APM Adjusted EBITDA Margin: Increased by 1 percentage point to 11%.

• Capital Expenditures: $84 million, an 18% decrease compared to the prior year.

• Free Cash Flow: Use of $196 million, compared to a use of $392 million in the prior year.

• Gross Debt: $4.1 billion with approximately $1.1 billion in total liquidity.

• Dividend Reduction: Declared a dividend for the second quarter at a reduced rate of $8.75 per share, reflecting a 65% reduction.

• Warning! GuruFocus has detected 8 Warning Signs with CC.

Release Date: May 07, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

• The Chemours Co (NYSE:CC) reported a 40% year-over-year net sales increase in Opteon Refrigerants, driven by increased demand for blend due to the US AIM Act transition mandate.

• The company successfully ramped up its 40% capacity expansion of Opteon feedstock at the Corpus Christi site, ensuring no disruption to customer orders despite a brief outage.

• Chemours' TSS business achieved a 30% adjusted EBITDA margin, positioning well for the peak cooling season.

• The company has a strategic agreement with Navin Fluorine to produce Opteon two-phase immersion cooling fluid, addressing data cooling center needs.

• Chemours anticipates a significant cash flow benefit of approximately $100 million to $115 million from the expiration of high-grade ore feedstock contracts by 2027.

Negative Points

• Chemours reported a net loss of $4 million for the first quarter, compared to a net income of $54 million in the prior year.

• The company's adjusted EBITDA decreased to $166 million from $191 million in the prior year, primarily due to lower pricing and unfavorable currency movements.

• Chemours' TT segment faced challenges with lower pricing and additional costs from plant downtime due to cold weather.

• The APM segment experienced a 3% decrease in net sales due to weakened cyclical end markets and products serving the hydrogen market.

• Chemours reduced its dividend by 65% to $8.75 per share to balance capital return to shareholders with balance sheet flexibility.